4.8 Review

BODIPY dyes in photodynamic therapy

Journal

CHEMICAL SOCIETY REVIEWS
Volume 42, Issue 1, Pages 77-88

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c2cs35216h

Keywords

-

Funding

  1. National Institutes of Health [GM087981]
  2. Robert A. Welch Foundation [A-1121]
  3. HIR-MOHE, Ministry of Higher Education, Malaysia [UM.C/625/1/HIR/MOHE/MED/17]
  4. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087981] Funding Source: NIH RePORTER

Ask authors/readers for more resources

BODIPY dyes tend to be highly fluorescent, but their emissions can be attenuated by adding substituents with appropriate oxidation potentials. Substituents like these have electrons to feed into photoexcited BODIPYs, quenching their fluorescence, thereby generating relatively long-lived triplet states. Singlet oxygen is formed when these triplet states interact with O-3(2). In tissues, this causes cell damage in regions that are illuminated, and this is the basis of photodynamic therapy (PDT). The PDT agents that are currently approved for clinical use do not feature BODIPYs, but there are many reasons to believe that this situation will change. This review summarizes the attributes of BODIPY dyes for PDT, and in some related areas.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available